nitrates has been researched along with fenofibrate in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, MF; Jiang, JL; Li, YJ; Luo, BL; Yang, TL; Yu, J | 1 |
| Ahn, JY; Ahn, TH; Choi, IS; Han, SH; Jeong, EM; Jin, DK; Kim, HS; Koh, KK; Shin, EK | 1 |
| Balakumar, P; Kaur, J; Reddy, K | 1 |
| Mohammadi, MT; Sahebkar, A; Yaribeygi, H | 1 |
1 trial(s) available for nitrates and fenofibrate
| Article | Year |
|---|---|
Comparative effects of statin and fibrate on nitric oxide bioactivity and matrix metalloproteinase in hyperlipidemia.
Topics: Brachial Artery; Coronary Artery Disease; Female; Fenofibrate; Humans; Hyperlipidemias; Hypolipidemic Agents; Lipids; Male; Matrix Metalloproteinases; Middle Aged; Nitrates; Nitric Oxide; Simvastatin; Tissue Inhibitor of Metalloproteinase-1; Tumor Necrosis Factor-alpha; Vasodilation | 2004 |
3 other study(ies) available for nitrates and fenofibrate
| Article | Year |
|---|---|
Effect of fenofibrate on LDL-induced endothelial dysfunction in rats.
Topics: Acetylcholine; Animals; Anti-Inflammatory Agents; Aorta, Thoracic; Arginine; Creatinine; Endothelium, Vascular; Fenofibrate; Hypolipidemic Agents; In Vitro Techniques; Male; Malondialdehyde; Muscle, Smooth, Vascular; Nitrates; Nitrites; Phenylephrine; Rats; Rats, Sprague-Dawley; Tumor Necrosis Factor-alpha; Vasodilation | 2004 |
The novel role of fenofibrate in preventing nicotine- and sodium arsenite-induced vascular endothelial dysfunction in the rat.
Topics: Animals; Arsenites; Cholesterol; Endothelium, Vascular; Fenofibrate; Hypolipidemic Agents; In Vitro Techniques; Lipid Metabolism; Lipoproteins, HDL; Microscopy, Electron, Scanning; Nicotine; Nicotinic Antagonists; Nitrates; Nitrites; Rats; Rats, Wistar; Sodium Compounds; Superoxides; Thiobarbituric Acid Reactive Substances; Triglycerides; Vascular Diseases | 2010 |
PPAR-α Agonist Improves Hyperglycemia-Induced Oxidative Stress in Pancreatic Cells by Potentiating Antioxidant Defense System.
Topics: Animals; Antioxidants; Catalase; Diabetes Mellitus, Experimental; Fenofibrate; Glutathione; Hyperglycemia; Male; Malondialdehyde; Nitrates; Oxidative Stress; Pancreas; PPAR alpha; Rats; Superoxide Dismutase | 2018 |